Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

492

Participants

Timeline

Start Date

February 28, 2005

Conditions
Nausea and VomitingChemotherapy-Induced
Interventions
DRUG

Aprepitant

DRUG

Ondansetron

DRUG

GW679769

DRUG

Dexamethasone

Trial Locations (51)

112

GSK Investigational Site, Taipei

114

GSK Investigational Site, Taipei

333

GSK Investigational Site, Tao Yuan County

1101

GSK Investigational Site, Quezon City

1529

GSK Investigational Site, Budapest

1700

GSK Investigational Site, Taft Avenue, Manila

2650

GSK Investigational Site, Edegem

3000

GSK Investigational Site, Leuven

4020

GSK Investigational Site, Liège

8000

GSK Investigational Site, Székesfehérvár

9000

GSK Investigational Site, Ghent

10000

GSK Investigational Site, Zagreb

12808

GSK Investigational Site, Prague

26841

GSK Investigational Site, Casalpusterlengo (LO)

34000

GSK Investigational Site, Durango

54000

GSK Investigational Site, Karachi

56124

GSK Investigational Site, Pisa

80131

GSK Investigational Site, Napoli

82100

GSK Investigational Site, Benevento

97500

GSK Investigational Site, Mérida

119074

GSK Investigational Site, Singapore

7500921

GSK Investigational Site, Santiago

C1437JCP

GSK Investigational Site, Capital Federal

C1405CBA

GSK Investigational Site, Buenos Aires

A-5020

GSK Investigational Site, Salzburg

A-1090

GSK Investigational Site, Vienna

A-1130

GSK Investigational Site, Vienna

Unknown

GSK Investigational Site, Santiago

GSK Investigational Site, Shatin, N.T.

GSK Investigational Site, Lahore

500 05

GSK Investigational Site, Hradec Králové

708 52

GSK Investigational Site, Ostrava - Poruba

154 00

GSK Investigational Site, Prague

180 81

GSK Investigational Site, Prague

00149

GSK Investigational Site, Rome

00184

GSK Investigational Site, Rome

07100

GSK Investigational Site, Sassari

06156

GSK Investigational Site, Perugia

1066 CX

GSK Investigational Site, Amsterdam

1081 HV

GSK Investigational Site, Amsterdam

6815 AD

GSK Investigational Site, Arnhem

3045 PM

GSK Investigational Site, Rotterdam

3527 CE

GSK Investigational Site, Utrecht

Callao 1

GSK Investigational Site, Callao

85-796

GSK Investigational Site, Bydogoszcz

31-115

GSK Investigational Site, Krakow

60-569

GSK Investigational Site, Poznan

61-866

GSK Investigational Site, Poznan

022328

GSK Investigational Site, Bucharest

041 90

GSK Investigational Site, Košice

949 88

GSK Investigational Site, Nitra

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY